Chemical-induced asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cerebral Hypoxia-Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Erythema Infectiosum
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Bronchiolitis, Viral
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Familial erythrocytosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.020 |
None |
1.000 |
2 |
|
1999 |
1999 |
Mammary Analogue Secretory Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2015 |
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
|
disease |
|
Disease or Syndrome
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Secretory breast carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Laron Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
20
|
26
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Chronic osteomyelitis
|
disease |
Infections; Musculoskeletal Diseases
|
Disease or Syndrome
|
21
|
12
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
IMMUNODEFICIENCY 13
|
disease |
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Myelofibrosis due to another disorder
|
disease |
|
Disease or Syndrome
|
23
|
6
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Menstrual spotting
|
phenotype |
|
Sign or Symptom
|
27
|
2
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Erythrocytosis familial, 1
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
14
|
0.020 |
None |
1.000 |
2 |
|
1999 |
1999 |
Lymphoid neoplasm
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hypergammaglobulinemia
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
36
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Olfactory Neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
38
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic eosinophilic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
9
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Achondroplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
46
|
21
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Complex Regional Pain Syndromes
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
47
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hyperprolactinemia
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
48
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cholesterol gallstones
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
51
|
12
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Node-negative breast cancer
|
disease |
|
Neoplastic Process
|
54
|
2
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lipomatosis, Multiple
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
61
|
59
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |